ANSLY
Price
$79.00
Change
-$0.49 (-0.62%)
Updated
Aug 5 closing price
Capitalization
3.3B
VERO
Price
$2.23
Change
-$0.05 (-2.19%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
4.24M
Interact to see
Advertisement

ANSLY vs VERO

Header iconANSLY vs VERO Comparison
Open Charts ANSLY vs VEROBanner chart's image
Ansell
Price$79.00
Change-$0.49 (-0.62%)
Volume$200
Capitalization3.3B
Venus Concept
Price$2.23
Change-$0.05 (-2.19%)
Volume$125
Capitalization4.24M
ANSLY vs VERO Comparison Chart in %
Loading...
ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANSLY vs. VERO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANSLY is a Buy and VERO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ANSLY: $79.00 vs. VERO: $2.28)
Brand notoriety: ANSLY and VERO are both not notable
ANSLY represents the Pharmaceuticals: Other, while VERO is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ANSLY: 115% vs. VERO: 27%
Market capitalization -- ANSLY: $3.3B vs. VERO: $4.24M
ANSLY [@Pharmaceuticals: Other] is valued at $3.3B. VERO’s [@Medical/Nursing Services] market capitalization is $4.24M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANSLY’s FA Score shows that 1 FA rating(s) are green whileVERO’s FA Score has 1 green FA rating(s).

  • ANSLY’s FA Score: 1 green, 4 red.
  • VERO’s FA Score: 1 green, 4 red.
According to our system of comparison, ANSLY is a better buy in the long-term than VERO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANSLY’s TA Score shows that 4 TA indicator(s) are bullish while VERO’s TA Score has 2 bullish TA indicator(s).

  • ANSLY’s TA Score: 4 bullish, 2 bearish.
  • VERO’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, ANSLY is a better buy in the short-term than VERO.

Price Growth

ANSLY (@Pharmaceuticals: Other) experienced а +1.44% price change this week, while VERO (@Medical/Nursing Services) price change was -1.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.39%. For the same industry, the average monthly price growth was +7.03%, and the average quarterly price growth was +18.51%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.21%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +24.78%.

Industries' Descriptions

@Pharmaceuticals: Other (-1.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.21% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANSLY($3.3B) has a higher market cap than VERO($4.24M). ANSLY YTD gains are higher at: -4.287 vs. VERO (-44.947). ANSLY has more cash in the bank: 88.5M vs. VERO (3.88M). VERO has less debt than ANSLY: VERO (37.1M) vs ANSLY (806M).
ANSLYVEROANSLY / VERO
Capitalization3.3B4.24M77,896%
EBITDAN/A-32.3M-
Gain YTD-4.287-44.94710%
P/E Ratio31.86N/A-
RevenueN/A60.1M-
Total Cash88.5M3.88M2,282%
Total Debt806M37.1M2,173%
FUNDAMENTALS RATINGS
ANSLY vs VERO: Fundamental Ratings
ANSLY
VERO
OUTLOOK RATING
1..100
3412
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
88100
PRICE GROWTH RATING
1..100
6087
P/E GROWTH RATING
1..100
57100
SEASONALITY SCORE
1..100
1350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANSLY's Valuation (17) in the null industry is in the same range as VERO (26). This means that ANSLY’s stock grew similarly to VERO’s over the last 12 months.

ANSLY's Profit vs Risk Rating (100) in the null industry is in the same range as VERO (100). This means that ANSLY’s stock grew similarly to VERO’s over the last 12 months.

ANSLY's SMR Rating (88) in the null industry is in the same range as VERO (100). This means that ANSLY’s stock grew similarly to VERO’s over the last 12 months.

ANSLY's Price Growth Rating (60) in the null industry is in the same range as VERO (87). This means that ANSLY’s stock grew similarly to VERO’s over the last 12 months.

ANSLY's P/E Growth Rating (57) in the null industry is somewhat better than the same rating for VERO (100). This means that ANSLY’s stock grew somewhat faster than VERO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANSLYVERO
RSI
ODDS (%)
Bearish Trend 2 days ago
52%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
40%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
45%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
37%
Bullish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
39%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVFKX84.201.10
+1.32%
Smead Value R2
LSCGX22.420.22
+0.99%
Loomis Sayles Global Growth C
ADSIX24.760.21
+0.86%
American Century Disciplined Growth Inv
RAMHX37.560.23
+0.62%
American Funds American Balanced R2E
TPISX13.660.03
+0.22%
Nuveen Quant Intl Small Cap Eq Premier

ANSLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANSLY has been loosely correlated with BRSYF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ANSLY jumps, then BRSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANSLY
1D Price
Change %
ANSLY100%
+1.44%
BRSYF - ANSLY
61%
Loosely correlated
N/A
VERO - ANSLY
38%
Loosely correlated
+4.11%
IOBCF - ANSLY
35%
Loosely correlated
N/A
FSPKF - ANSLY
22%
Poorly correlated
N/A
APYX - ANSLY
21%
Poorly correlated
+7.89%
More

VERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERO has been loosely correlated with ANSLY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VERO jumps, then ANSLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERO
1D Price
Change %
VERO100%
+4.11%
ANSLY - VERO
38%
Loosely correlated
+1.44%
CRL - VERO
35%
Loosely correlated
-0.01%
ISRG - VERO
35%
Loosely correlated
+3.02%
ATR - VERO
33%
Loosely correlated
+2.40%
RVTY - VERO
33%
Poorly correlated
+2.81%
More